Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8794168 | Ophthalmology | 2018 | 9 Pages |
Abstract
Fluorescein angiography has shown potentially serious and long-term ocular effects that are present more commonly after treatment with bevacizumab for acute-phase ROP than after laser.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Domenico MD, Graham E. MD, MSCE, Fernando MD, Lorenzo MD, Antonio MD, Marco H. MD, Maria MD, Fabio MD, Daniela MD, Eugenio MD,